title: Advances in endovascular therapy to treat primary hepatocellular carcinoma.
abstract: Transcatheter arterial chemoembolization (TACE) is a minimally invasive procedure to restrict a tumor's blood supply, and TACE has an established role in cancer therapy. An embolic material in the form of microspheres (such as drug-eluting beads) and transarterial radioembolization is effective at treating hepatocellular carcinoma (HCC). Endovascular therapy offers promise for the treatment of tumor thrombi in the portal vein. Many researchers are anticipating an era of TACE with microspheres. This review aims to provide an overview of advances in endovascular therapy to treat primary HCC.
authors.affiliation: Department of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Cancer Research Center, Key Laboratory of Cancer Prevention and Therapy.
authors.forename: Zhi
authors.initials: Z
authors.lastname: Guo
authors.forename: Haipeng
authors.initials: H
authors.lastname: Yu
authors.forename: Changfu
authors.initials: C
authors.lastname: Liu
authors.forename: Tongguo
authors.initials: T
authors.lastname: Si
authors.forename: Xueling
authors.initials: X
authors.lastname: Yang
authors.forename: Weihao
authors.initials: W
authors.lastname: Zhang
authors.forename: Yan
authors.initials: Y
authors.lastname: Xu
authors.forename: Yong
authors.initials: Y
authors.lastname: Li
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D016461:Chemoembolization, Therapeutic / Q000009:adverse effects / Q000379:methods / Q000639:trends; D004059:Diffusion of Innovation; D004337:Drug Carriers; D057510:Endovascular Procedures / Q000009:adverse effects / Q000379:methods* / Q000401:mortality / Q000639:trends; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D008863:Microspheres; D019275:Radiopharmaceuticals / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D004337:Drug Carriers; D019275:Radiopharmaceuticals